20s Male Hospitalized for Suspected Thrombosis After Vaccination... "Underlying Conditions Under Investigation" (Update)

First Responders Vaccinated... "No Similar Adverse Symptoms Among Those Vaccinated with the Same Vaccine"

On the afternoon of the 15th, medical staff demonstrated the preparation process of the AstraZeneca (AZ) vaccine at the COVID-19 vaccination center set up in the auditorium of Seongdong-gu Office in Seoul. Photo by Mun Ho-nam munonam@

[Asia Economy Reporter Seo So-jeong] It has been confirmed that a man in his 20s, who received the AstraZeneca COVID-19 vaccine as a first responder, is currently hospitalized for suspected thrombosis.

Park Young-jun, head of the Adverse Reaction Investigation Support Team at the COVID-19 Vaccination Promotion Task Force, stated at the regular briefing of the Central Disease Control Headquarters on the 18th, "Mr. A, a man in his 20s who reported thrombosis, received the AstraZeneca vaccine as a first responder."

Park explained, "Mr. A experienced headaches and chills on the 10th and 11th after receiving the vaccination on the 10th. Later, his symptoms worsened, and on the 14th, his headaches and vomiting did not improve. He visited a medical institution on the 15th and was discharged, but as symptoms persisted, he underwent additional tests."

Park added, "On the 16th, he received additional blood tests and radiological examinations, and thrombosis was confirmed through radiological findings. This case was reported to the adverse reaction reporting system on the 17th."

He continued, "An investigation into Mr. A’s underlying conditions is currently underway. Once the epidemiological investigation is completed, a causality assessment will be conducted regarding this case."

Park also stated, "After the report was received, the relevant health authorities conducted a preliminary investigation and have been monitoring for any adverse reactions among individuals vaccinated with the same vaccine at the same institution. So far, there have been no similar adverse symptoms reported among those vaccinated at the same institution with the same vaccine."

This content was produced with the assistance of AI translation services.